Product Code: 4666
Global embolotherapy market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.
Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.
The global embolotherapy market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.
The global embolotherapy market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the global embolotherapy market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.
Major players operating in the global embolotherapy market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the global embolotherapy market.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021-2025
Objective of the Study
- To analyze and forecast the market size of global embolotherapy market.
- To classify and forecast global embolotherapy market based on indication, product, type, end-user and regional distribution.
- To identify drivers and challenges for global embolotherapy market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global embolotherapy market.
- To conduct pricing analysis for global embolotherapy market.
- To identify and analyze the profile of leading players operating in global embolotherapy market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.
TechSci Research calculated the market size of global embolotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience
- Embolotherapy hospitals/clinics, research organizations and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to embolotherapy
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope
In this report, global embolotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Cancer
Gastrointestinal Disorders
Neurological Diseases
Peripheral Vascular Disease
Urological & Nephrological Disorders
Embolic Agents
- Embolic Coils
- Embolic Plug Systems
- Liquid Embolic Agents
- Microspheres
- Detachable Balloons
Support Devices
- Microcatheters
- Guidewires
- Market, By Type:
Chemoembolization
Radioembolization
Arterial Embolization
Combination
Hospitals
Clinics
Ambulatory Surgical Centers
Others
North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
Asia-Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
South America
- Brazil
- Argentina
- Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global embolotherapy market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Embolotherapy Market
4. Executive Summary
5. Voice of Customer
6. Global Embolotherapy Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
- 6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
- 6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
- 6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
- 6.2.5. By Company (2019)
- 6.2.6. By Region
- 6.3. Market Attractiveness Index
7. Asia-Pacific Embolotherapy Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Indication
- 7.2.2. By Embolic agents
- 7.2.3. By Types
- 7.2.4. By End-User
- 7.2.5. By Country
- 7.3. Market Attractiveness Index
- 7.4. Asia-Pacific: Country Analysis
- 7.4.1. China Embolotherapy Market Outlook
- 7.4.1.1. Market Size & Forecast
- 7.4.1.2. Market Share & Forecast
- 7.4.1.2.1. By Indication
- 7.4.1.2.2. By Embolic agents
- 7.4.1.2.3. By Types
- 7.4.1.2.4. By End-User
- 7.4.2. India Embolotherapy Market Outlook
- 7.4.2.1. Market Size & Forecast
- 7.4.2.2. Market Share & Forecast
- 7.4.2.2.1. By Indication
- 7.4.2.2.2. By Embolic agents
- 7.4.2.2.3. By Types
- 7.4.2.2.4. By End-User
- 7.4.3. Japan Embolotherapy Market Outlook
- 7.4.3.1. Market Size & Forecast
- 7.4.3.2. Market Share & Forecast
- 7.4.3.2.1. By Indication
- 7.4.3.2.2. By Embolic agents
- 7.4.3.2.3. By Types
- 7.4.3.2.4. By End-User
- 7.4.4. South Korea Embolotherapy Market Outlook
- 7.4.4.1. Market Size & Forecast
- 7.4.4.2. Market Share & Forecast
- 7.4.4.2.1. By Indication
- 7.4.4.2.2. By Embolic agents
- 7.4.4.2.3. By Types
- 7.4.4.2.4. By End-User
- 7.4.5. Singapore Embolotherapy Market Outlook
- 7.4.5.1. Market Size & Forecast
- 7.4.5.2. Market Share & Forecast
- 7.4.5.2.1. By Indication
- 7.4.5.2.2. By Embolic agents
- 7.4.5.2.3. By Types
- 7.4.5.2.4. By End-User
- 7.4.6. Australia Embolotherapy Market Outlook
- 7.4.6.1. Market Size & Forecast
- 7.4.6.2. Market Share & Forecast
- 7.4.6.2.1. By Indication
- 7.4.6.2.2. By Embolic agents
- 7.4.6.2.3. By Types
- 7.4.6.2.4. By End-User
8. Europe Embolotherapy Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Indication
- 8.2.2. By Embolic agents
- 8.2.3. By Types
- 8.2.4. By End-User
- 8.2.5. By Country
- 8.3. Market Attractiveness Index
- 8.4. Europe: Country Analysis
- 8.4.1. France Embolotherapy Market Outlook
- 8.4.1.1. Market Size & Forecast
- 8.4.1.2. Market Share & Forecast
- 8.4.1.2.1. By Indication
- 8.4.1.2.2. By Embolic agents
- 8.4.1.2.3. By Types
- 8.4.1.2.4. By End-User
- 8.4.2. Germany Embolotherapy Market Outlook
- 8.4.2.1. Market Size & Forecast
- 8.4.2.2. Market Share & Forecast
- 8.4.2.2.1. By Indication
- 8.4.2.2.2. By Embolic agents
- 8.4.2.2.3. By Types
- 8.4.2.2.4. By End-User
- 8.4.3. United Kingdom Embolotherapy Market Outlook
- 8.4.3.1. Market Size & Forecast
- 8.4.3.2. Market Share & Forecast
- 8.4.3.2.1. By Indication
- 8.4.3.2.2. By Embolic agents
- 8.4.3.2.3. By Types
- 8.4.3.2.4. By End-User
- 8.4.4. Italy Embolotherapy Market Outlook
- 8.4.4.1. Market Size & Forecast
- 8.4.4.2. Market Share & Forecast
- 8.4.4.2.1. By Indication
- 8.4.4.2.2. By Embolic agents
- 8.4.4.2.3. By Types
- 8.4.4.2.4. By End-User
- 8.4.5. Russia Embolotherapy Market Outlook
- 8.4.5.1. Market Size & Forecast
- 8.4.5.2. Market Share & Forecast
- 8.4.5.2.1. By Indication
- 8.4.5.2.2. By Embolic agents
- 8.4.5.2.3. By Types
- 8.4.5.2.4. By End-User
- 8.4.6. Spain Embolotherapy Market Outlook
- 8.4.6.1. Market Size & Forecast
- 8.4.6.2. Market Share & Forecast
- 8.4.6.2.1. By Indication
- 8.4.6.2.2. By Embolic agents
- 8.4.6.2.3. By Types
- 8.4.6.2.4. By End-User
9. North America Embolotherapy Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Indication
- 9.2.2. By Embolic agents
- 9.2.3. By Types
- 9.2.4. By End-User
- 9.2.5. By Country
- 9.3. Market Attractiveness Index
- 9.4. North America: Country Analysis
- 9.4.1. United States Embolotherapy Market Outlook
- 9.4.1.1. Market Size & Forecast
- 9.4.1.2. Market Share & Forecast
- 9.4.1.2.1. By Indication
- 9.4.1.2.2. By Embolic agents
- 9.4.1.2.3. By Types
- 9.4.1.2.4. By End-User
- 9.4.2. Mexico Embolotherapy Market Outlook
- 9.4.2.1. Market Size & Forecast
- 9.4.2.2. Market Share & Forecast
- 9.4.2.2.1. By Indication
- 9.4.2.2.2. By Embolic agents
- 9.4.2.2.3. By Types
- 9.4.2.2.4. By End-User
- 9.4.3. Canada Embolotherapy Market Outlook
- 9.4.3.1. Market Size & Forecast
- 9.4.3.2. Market Share & Forecast
- 9.4.3.2.1. By Indication
- 9.4.3.2.2. By Embolic agents
- 9.4.3.2.3. By Types
- 9.4.3.2.4. By End-User
10. South America Embolotherapy Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value & Volume
- 10.2. Market Share & Forecast
- 10.2.1. By Indication
- 10.2.2. By Embolic agents
- 10.2.3. By Types
- 10.2.4. By End-User
- 10.2.5. By Country
- 10.3. Market Attractiveness Index
- 10.4. South America: Country Analysis
- 10.4.1. Brazil Embolotherapy Market Outlook
- 10.4.1.1. Market Size & Forecast
- 10.4.1.2. Market Share & Forecast
- 10.4.1.2.1. By Indication
- 10.4.1.2.2. By Embolic agents
- 10.4.1.2.3. By Types
- 10.4.1.2.4. By End-User
- 10.4.2. Argentina Embolotherapy Market Outlook
- 10.4.2.1. Market Size & Forecast
- 10.4.2.2. Market Share & Forecast
- 10.4.2.2.1. By Indication
- 10.4.2.2.2. By Embolic agents
- 10.4.2.2.3. By Types
- 10.4.2.2.4. By End-User
- 10.4.3. Colombia Embolotherapy Market Outlook
- 10.4.3.1. Market Size & Forecast
- 10.4.3.2. Market Share & Forecast
- 10.4.3.2.1. By Indication
- 10.4.3.2.2. By Embolic agents
- 10.4.3.2.3. By Types
- 10.4.3.2.4. By End-User
11. Middle East and Africa Embolotherapy Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value & Volume
- 11.2. Market Share & Forecast
- 11.2.1. By Indication
- 11.2.2. By Embolic agents
- 11.2.3. By Types
- 11.2.4. By End-User
- 11.2.5. By Country
- 11.3. Market Attractiveness Index
- 11.4. MEA: Country Analysis
- 11.4.1. South Africa Embolotherapy Market Outlook
- 11.4.1.1. Market Size & Forecast
- 11.4.1.2. Market Share & Forecast
- 11.4.1.2.1. By Indication
- 11.4.1.2.2. By Embolic agents
- 11.4.1.2.3. By Types
- 11.4.1.2.4. By End-User
- 11.4.2. Saudi Arabia Embolotherapy Market Outlook
- 11.4.2.1. Market Size & Forecast
- 11.4.2.2. Market Share & Forecast
- 11.4.2.2.1. By Indication
- 11.4.2.2.2. By Embolic agents
- 11.4.2.2.3. By Types
- 11.4.2.2.4. By End-User
- 11.4.3. UAE Embolotherapy Market Outlook
- 11.4.3.1. Market Size & Forecast
- 11.4.3.2. Market Share & Forecast
- 11.4.3.2.1. By Indication
- 11.4.3.2.2. By Embolic agents
- 11.4.3.2.3. By Types
- 11.4.3.2.4. By End-User
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Competition Outlook
- 14.2. Players Profiled (Leading Companies)
- 14.2.1. Abbott Laboratories
- 14.2.2. ABK Biomedical Inc
- 14.2.3. Acandis GmbH
- 14.2.4. AngioDynamics Inc
- 14.2.5. Becton Dickinson and Company
- 14.2.6. Boston Scientific Corporation
- 14.2.7. Cook Medical
- 14.2.8. Guerbet
- 14.2.9. Imbiotechnologies Ltd.
- 14.2.10. Johnson & Johnson
- 14.2.11. Kaneka Corporation
- 14.2.12. Medtronic
- 14.2.13. Meril Life Sciences Pvt. Ltd.
- 14.2.14. Merit Medical Systems
- 14.2.15. Merit Medical Systems, Inc.
- 14.2.16. Penumbra, Inc.
- 14.2.17. Simbionix USA Corporation
- 14.2.18. Sirtex Medical Limited
- 14.2.19. Stryker Corporation
- 14.2.20. Terumo Corporation
15. Strategic Recommendations
16. About Us & Disclaimer
